Approved Treatments for Osteoporosis and What’s in the Pipeline
暂无分享,去创建一个
Mbbs | Alok Sachdeva | B. Goeckeritz | A. Oliver | S. Davis
[1] S. Adami,et al. Once-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated review. , 2009, Clinical therapeutics.
[2] S. Boonen,et al. Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance , 2008, Journal of internal medicine.
[3] S. Silverman,et al. Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] S. Cummings,et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. , 2006, JAMA.
[5] Sonal Singh,et al. Bisphosphonates and Atrial Fibrillation , 2009, Drug safety.
[6] M. Leonard,et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. , 2008, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.